Issue link: https://www.e-digitaleditions.com/i/1073928
Respiratory Drug Delivery (RDD®) Europe 2019 will be held May 7-10, 2019 in Lisbon, Portugal. Also, respiratory medicine news provides recent news items on R&D and progress in the treatment of respiratory diseases. 22 February 2019 Inhalation A preview of Respiratory Drug Delivery (RDD ® ) Europe 2019 R espiratory Drug Delivery (RDD ® ) Europe 2019 will be held May 7-10, 2019 in Lisbon, Portu- gal, at the the Estoril Congress Cen- ter, located 30 minutes from the Lisbon International Airport. Plenary lecture, sessions and workshops The plenary lecture, "Emerging Treatment Guidelines in COPD: Unravelling the Triple Therapy Trials," will be presented by Jad- wiga Wedzicha, MD, Professor of Respiratory Medicine, National Heart and Lung Institute, Imperial College London. Sessions will address: • New approaches to treating old diseases • Pipes, particles and predictions: New insights into deposition • Reinventing inhalers for the digital age • Take a deep breath: Brexit and environmental sustainability • New approaches to inhalation p r o d u c t d e v e l o p m e n t a n d production When? May 7-10, 2019 Where? Lisbon, Portugal For more information and registration: www.rddonline.com/rdd/rdd. php?id=17&sid=1 Twelve companies will present 60-minute interactive workshops and each attendee may participate in three workshops. Posters, exhibition, gala dinner A scientific poster session will be presented in conjunction with a technology exhibition to promote scientific discussion and network- ing and will last throughout the conference. In addition, a session w i l l f e a t u r e p o s t e r s o n t h e podium. A gala dinner will be held on ursday, May 9. RespiRatoRy medicine news Digital inhalers reduce emergency room asthma visits by half SAN FRANCICSO, CALIFOR- NIA—According to The Enter- prise, Dignity Health and Propeller Health have announced results of a study published in the World Allergy Organization Journal, showing that, among Dignity Health patients using Propeller's wireless inhalers for asthma man- agement, asthma-related emer- gency room visits decreased by 54 percent compared to the previous y e a r , a n d c o m b i n e d a s t h m a - related emergency room visits and hospitalizations decreased by 57 percent compared to the previous year. Propeller's digital medicine platform provides patients and cli- nicians information about rescue and controller medication use, symptoms and triggers. e study evaluated 224 patients, for 12 months, who had a diagnosis of persistent asthma. Chronic and allergic rhinitis influence hospital readmissions CINCINNATI, OHIO— Accord- ing to Medical Xpress, researchers from the University of Cincinnati studied medical outcomes and hos- pital readmissions for 4,754 asthma patients and 2,176 COPD patients in a five-year period. e researchers determined that asthmatics with allergic rhinitis were 4.4 times more likely to be readmitted within 30 days compared to asthmatics with- out allergic rhinitis. Asthmatics with non-allergic rhinitis were 3.7 times more likely to be readmitted than those without non-allergic rhinitis. For COPD patients, rates were 2.4 times and 2.6 times, respectively. Coauthor Jonathan Bernstein, MD believes the findings could encour- age physicians to consider upper respiratory disease when treating asthma and COPD patients. Find- ings were published in the Journal of Allergy and Clinical Immunology.